LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis (UC)
50 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07415044·Phase 2·Recruiting·Listed Feb 2026
Northwestern University
Clinical research site in Chicago, Illinois · 303 E CHICAGO AVE, TARRY BUILDING, 11-703, CHICAGO, IL 60611-3008 · (312) 503-0830 · Website
Part of Northwestern University
As of July 2026, 323 paid clinical trials are recruiting at Northwestern University in Chicago, Illinois. Active studies at this site cover conditions such as Prostate Adenocarcinoma, Stage IV Lung Cancer AJCC v8 and Acute Myeloid Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Northwestern University (323)
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
for Diabetic Peripheral Neuropathic Pain
36 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07285018·Phase 2·Recruiting·Listed Dec 2025
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
for Type 1 Diabetes Mellitus
31 locations incl. Little Rock
Sponsor: Medtronic MiniMed, Inc.
Sex: All·Age: 7 - 85
Code: NCT07228117·Recruiting·Listed Nov 2025
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for Focal Segmental Glomerulosclerosis
66 locations incl. Alabaster
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT07220083·Phase 3·Recruiting·Listed Oct 2025
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for Ulcerative Colitis
40 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07186101·Phase 2·Recruiting·Listed Sep 2025
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for Non-small Cell Lung Cancer
28 locations incl. Fresno
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07195695·Phase 3·Recruiting·Listed Sep 2025
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
for Osteoarthritis
26 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07153471·Phase 3·Recruiting·Listed Sep 2025
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
for Breast Neoplasms
39 locations incl. Birmingham
Sponsor: Natera, Inc.
Sex: All·Age: 18+
Code: NCT07214532·Recruiting·Listed Oct 2025
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for Diabetes Mellitus, Type 2
123 locations incl. Chandler
Sponsor: Cleerly, Inc.
Sex: All·Age: 55+·Accepts healthy volunteers
Code: NCT06112418·Recruiting·Listed Nov 2023
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
for Osteoarthritis, Knee
41 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT05986292·Phase 2·Recruiting·Listed Aug 2023
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for Primary Biliary Cholangitis
51 locations incl. Birmingham
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT06051617·Phase 3·Recruiting·Listed Sep 2023
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for Chronic Lymphocytic Leukemia
35 locations incl. Laguna Hills
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06943872·Phase 3·Recruiting·Listed Apr 2025
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
for Depressive Disorder, Major
43 locations incl. Tucson
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18 - 74
Code: NCT06559306·Phase 3·Recruiting·Listed Aug 2024
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for Multiple Myeloma
28 locations incl. Phoenix
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05201781·Phase 4·Recruiting·Listed Jan 2022
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
for Bronchiectasis
57 locations incl. Anchorage
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT06872892·Phase 3·Recruiting·Listed Mar 2025
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
for Tricuspid Regurgitation
46 locations incl. Irvine
Sponsor: Edwards Lifesciences
Sex: All·Age: 18+
Code: NCT04097145·Recruiting·Listed Sep 2019
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
for Dermatitis Atopic
43 locations incl. Birmingham
Sponsor: Sanofi
Sex: All·Age: 12+
Code: NCT06241118·Phase 3·Recruiting·Listed Feb 2024
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for Interstitial Lung Diseases
33 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06806592·Phase 3·Recruiting·Listed Feb 2025
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
for Areata Alopecia
41 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 6 - 17
Code: NCT05723198·Phase 3·Recruiting·Listed Feb 2023
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
for Triple Negative Breast Cancer
26 locations incl. Phoenix
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05377996·Phase 1, Phase 2·Recruiting·Listed May 2022
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
for Kidney Disease, Chronic
42 locations incl. Huntsville
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06531824·Phase 3·Recruiting·Listed Aug 2024
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
66 locations incl. Birmingham
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT06388421·Recruiting·Listed Apr 2024
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
for Perennial Allergic Rhinitis (PAR)
27 locations incl. Huntington Beach
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06339008·Phase 3·Recruiting·Listed Apr 2024
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
23 locations incl. Los Angeles
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT04302025·Phase 2·Recruiting·Listed Mar 2020
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for Prostate Cancer
25 locations incl. Palo Alto
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06855277·Phase 3·Recruiting·Listed Mar 2025
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
for Lung Transplant Rejection
32 locations incl. Birmingham
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06082037·Phase 3·Recruiting·Listed Oct 2023
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
for Non-Muscle Invasive Bladder Neoplasms
21 locations incl. Birmingham
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05316155·Phase 1, Phase 2·Recruiting·Listed Apr 2022
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
for Pulmonary Hypertension
30 locations incl. Birmingham
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT06911632·Recruiting·Listed Apr 2025
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
for Focal Epilepsy
48 locations incl. Phoenix
Sponsor: Biohaven Therapeutics Ltd.
Sex: All·Age: 18 - 75
Code: NCT06132893·Phase 2, Phase 3·Recruiting·Listed Nov 2023
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for Refractory Angina
65 locations incl. Phoenix
Sponsor: Shockwave Medical, Inc.
Sex: All·Age: 18+
Code: NCT05102019·Recruiting·Listed Nov 2021
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for Breast Cancer
79 locations incl. Phoenix
Sponsor: BriaCell Therapeutics Corporation
Sex: All·Age: 18+
Code: NCT06072612·Phase 3·Recruiting·Listed Oct 2023
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
46 locations incl. Chandler
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT06598943·Phase 2·Recruiting·Listed Sep 2024
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
for Osteoarthritis, Knee
40 locations incl. Peoria
Sponsor: Paradigm Biopharmaceuticals Ltd.
Sex: All·Age: 18+
Code: NCT06917404·Phase 3·Recruiting·Listed Apr 2025
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
37 locations incl. Tucson
Sponsor: Intellia Therapeutics
Sex: All·Age: 18 - 90
Code: NCT06128629·Phase 3·Recruiting·Listed Nov 2023
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
for Venous Thromboses
25 locations incl. Stanford
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT05489588·Recruiting·Listed Aug 2022
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
37 locations incl. Little Rock
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for cGVHD
31 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT05919511·Recruiting·Listed Jun 2023
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
for Gastroesophageal-junction Cancer
29 locations incl. Anaheim
Sponsor: Shanghai Henlius Biotech
Sex: All·Age: 18+
Code: NCT06532006·Phase 3·Recruiting·Listed Aug 2024
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for Gastrointestinal Stromal Tumor (GIST)
32 locations incl. Birmingham
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06655246·Phase 1·Recruiting·Listed Oct 2024
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
for Advanced Gastrointestinal Stromal Tumors
8 locations incl. Washington D.C.
Sponsor: Cogent Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT05208047·Phase 3·Recruiting·Listed Jan 2022
Showing the 40 most relevant of 323 recruiting trials at this site. Browse all with filters →
More research sites in Chicago
- University of Chicago (182 trials)
- Rush University Medical Center (151 trials)
- Ann & Robert H. Lurie Children's Hospital of Chicago (113 trials)
- University of Chicago Medical Center (98 trials)
- Northwestern Memorial Hospital (87 trials)
- University of Chicago Comprehensive Cancer Center (87 trials)
- University of Illinois (84 trials)
- University of Illinois at Chicago (72 trials)
- Advocate Illinois Masonic Medical Center (50 trials)
- The University of Chicago (41 trials)
Explore more
Paid clinical trials in Chicago, IL · Illinois clinical trials